The manufacturers of a new weight-loss drug recently rolled out by the NHS are upping their prices by 170%.

Eli Lilly is increasing the price of Mounjaro, which is also used to treat type 2 diabetes, in the UK from September.

It comes amid a White House push to get drug makers to raise their prices overseas in order to cut prices in the US.

The price for a month’s supply of the highest dose of Mounjaro, a 15mg KwikPen, will increase from £122 to £330.

The cost of a 2.5mg pen, the lowest dose available, will rise from £92 to £133 from September 1.

This means the annual cost of the 15mg dose will increase from £1,586 a year to £4,290. This higher price will affect anyone in the UK who pays for the medicine privately.

However, it doesn’t impact those who are prescribed the medicine thro

See Full Page